D-1693-2012 Class II Terminated
FDA drug recall D-1693-2012 was initiated by Actavis on Jul 11, 2012 and is designated Class II. Reason for recall: Subpotent; some patches may not contain fentanyl gel The recall status is terminated (terminated Apr 10, 2013). Affected quantity: 98,088 cartons (5 pouches per carton).
Recall details
- Product Type
- Drugs
- Report Date
- Oct 3, 2012
- Initiation Date
- Jul 11, 2012
- Termination Date
- Apr 10, 2013
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 98,088 cartons (5 pouches per carton)
Product description
Fentanyl Transdermal System, 100 mcg/h, each transdermal system contains: 10 mg fentanyl and 0.4 mL alcohol USP, Rx only, supplied in single pouches (NDC 0591-3214-54 (pouch)), 5 pouches per carton (NDC 0591-3214-72 (Carton)), Manufactured by Watson laboratories Inc., Corona, CA, Distributed by: Watson, Pharma Inc.
Reason for recall
Subpotent; some patches may not contain fentanyl gel
Distribution pattern
Nationwide
Code information
Lot number 455040A (carton) 455040 (pouch)
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1693-2012
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026